It has been shown that IL-6 could activate STAT3 through Janus-activated kinases (Jak) (Wang et al., 2013), and rheumatoid arthritis patients treated with anti-Jak inhibitors in vitro saw an inhibition of lymphocyte autophagy (Vomero et al., 2020). Here, STAT3 is linked to rheumatoid arthritis.